SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 27 Sep, 2014  

SIRO Clinpharm Announces Bolstering its Operations in Europe

PR Newswire | 29 Mar, 2012
MUMBAI, India: SIRO Clinpharm, a leading full service Clinical Research Organization announced its plans to further strengthen its operations in Europe in the areas of Biostatistics, Data Management and Clinical Trials. SIRO Clinpharm Germany GmbH at Offenbach in Germany will act as a hub for this purpose.

"Our European business has been operational for 19 years and we have been serving customers for many years with great success," said Gopakumar Menon recently appointed as Chief Executive Officer at SIRO Clinpharm. "My vision is to leverage this experience and expertise coupled with SIRO's geographic reach in the Eastern European and Asian region, build and deliver innovative solutions to global biopharma clients." 

"We have been delivering solutions of highest quality on a consistent basis for many years in Biostatistics studies to our biopharma clients," said Thomas Deller, Senior Vice President and Global Head Biostatistics and Programming, SIRO Clinpharm Germany GmbH.  "Our capabilities include not only providing essential services in the biostatistics & programming spectrum like input to study protocol design and SAP creation but also high end services like DSMB or DMC and Data Mapping services."

"With a dynamic regulatory landscape, the continued pressure on pricing and dwindling pipelines, the bottom line for today's European biopharma is squeezed like never before," said Timothy Scane, PhD, Senior Director Business Development, SIRO Clinpharm Germany GmbH.  "While our customers demand high quality, they also demand cost efficiencies within the context of the current business climate. This is where an organization like SIRO can offer solutions with its capabilities coupled with its presence in emerging markets."         

About SIRO

SIRO Clinpharm, winner of the Frost & Sullivan Indian Clinical Research Organization of the year 2011 award is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in data management, medical writing, biostatistics & clinical trial management. Having a successful track record of 16 years, SIRO works with most top global biopharma & medical device companies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology, infectious diseases & respiratory system. We offer flexible business models across service verticals based on client needs.

The company has offices in India, Malaysia, USA, and Israel and in Europe at Germany, Romania, Estonia, Greece, Czech Republic and Spain.

For more information please visit our website- http://www.siroclinpharm.com

 

Media contact:
Ruchi Sanganeria
Corporate Marketing
Tel: +91-22-2584-8000
ruchi.sanganeria@siroclinpharm.com

SOURCE SIRO Clinpharm

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Yes
 No
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter